Fracture Preventing Effects of Maxmarvil® Tablets (Alendronate 5 mg + Calcitriol 0.5 µg) in Patients with Osteoporosis

BACKGROUND: The purpose of this prospective, open-label, observational study was to assess the fracture preventing effect of Maxmarvil® tablets (alendronate 5 mg + calcitriol 0.5 µg) in patients with osteoporosis and to evaluate the change in bone mineral density (BMD) at the minimum 1-year follow-u...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Jun-Il, Ha, Yong-Chan, Won, Ye-Yeon, Yang, Kyu-Hyun, Kim, Sang-Bum, Yoo, Ju-Hyung, Kim, Dong-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Bone and Mineral Research 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472803/
https://www.ncbi.nlm.nih.gov/pubmed/28642852
http://dx.doi.org/10.11005/jbm.2017.24.2.91

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472803/
https://www.ncbi.nlm.nih.gov/pubmed/28642852
http://dx.doi.org/10.11005/jbm.2017.24.2.91

Ejemplares similares